ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

January 13, 2012

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.

March 12, 2004

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

CCOP Recompetition Approved, “Institutionalized;” Board Okays Concept For Eight Minority CCOPs

February 3, 1989